TWO2® therapy to be included in NHS supply chain framework agreement for 2025

by Mary Anne Brigham | Apr 22, 2025 | Press

AOTI Awarded Five Year Extension To Veterans Administration Contract

by Mary Anne Brigham | Dec 12, 2024 | Press

AOTI, INC. (the “Company” or “Group” or “AOTI”) AOTI Awarded Five Year Extension To Veterans Administration Contract AOTI, INC., a medical technology group focused on the durable healing of wounds and prevention of amputations, is...

AOTI announces US FDA 510(k) Clearance of NEXA NPWT System for use in the home care setting

by Mary Anne Brigham | Jul 29, 2024 | Press

Treatment Recommendation for Diabetic Foot Ulcers (DFUs) by the Wound Healing Society

by Mike Hughes | Dec 4, 2023 | Press

AOTI’s at-home TWO2® therapy is able to deliver oxygen topically into chronic wounds, including Diabetic Foot Ulcers (DFUs), and to encourage high-quality, durable wound healing OCEANSIDE, Calif., Dec. 4, 2023 /PRNewswire/ — AOTI Inc., the global leader in...

AOTI to Present Keynote at Advanced Wound Care Summit Europe

by Mike Hughes | Nov 27, 2023 | Press

Dr. Mike Griffiths to lead discussions on durable wound healing at summit dedicated to advancing commercialization of cutting-edge wound care products OCEANSIDE, Calif., Nov. 27, 2023 /PRNewswire/ — AOTI Inc., the global leader in multimodality topical wound...

AOTI Participates in Panel Discussion at Preventing Diabetes-Related Amputations in America

by Mike Hughes | Jul 14, 2023 | Press

OCEANSIDE, Calif., July 14, 2023 /PRNewswire/ — AOTI Inc., the global leader in multimodality topical wound oxygen therapy, participated as a founding member of the Amputation Prevention Alliance (APA), in the “Preventing Diabetes-Related Amputations in...